CytoDyn Inc.
CYDY
$0.204
$0.0031.49%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.76M | -4.77M | 19.23M | -16.79M | -11.92M |
| Total Depreciation and Amortization | 5.00K | 4.00K | 5.00K | 4.00K | 7.00K |
| Total Amortization of Deferred Charges | 110.00K | 113.00K | 125.00K | 125.00K | 612.00K |
| Total Other Non-Cash Items | 13.00K | 457.00K | 2.17M | 9.67M | 6.73M |
| Change in Net Operating Assets | -326.00K | 608.00K | -16.09M | 5.34M | 2.24M |
| Cash from Operations | -4.96M | -3.59M | 5.44M | -1.65M | -2.34M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 954.00K |
| Total Debt Repaid | 0.00 | 0.00 | -710.00K | -- | -- |
| Issuance of Common Stock | 21.00K | -- | -- | 3.44M | 2.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 10.38M | -- | -- |
| Cash from Financing | 21.00K | 0.00 | 9.67M | 3.44M | 3.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.94M | -3.59M | 15.11M | 1.79M | 1.30M |